RPC Pharma Ltd 13D and 13G filings for Akari Therapeutics, Plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-06-20 07:30 am Purchase | 2024-05-31 | 13D | Akari Therapeutics, Plc AKTX | RPC Pharma Ltd | 4,507,314,800 19.200% | 1,022,356,900 (+29.34%) | Filing |
| 2024-01-04 12:34 pm Purchase | 2024-01-01 | 13D | Akari Therapeutics, Plc AKTX | RPC Pharma Ltd | 3,484,957,900 26.400% | 3,484,957,900 (New Position) | Filing |